Related Experiment Video

Updated: Apr 19, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.7K

Prediction and management of cardiovascular outcomes in systemic lupus erythematosus

Johan Frostegård1

  • 1IMM, Karolinska Institutet, Unit of Immunology and chronic disease, 171 75 Stockholm, Sweden.

Expert Review of Clinical Immunology
|December 18, 2014
PubMed

Insights

Atherosclerosis, a chronic inflammatory condition, significantly increases cardiovascular disease (CVD) risk in systemic lupus erythematosus patients. Understanding both traditional and non-traditional risk factors is crucial for predicting and managing CVD in this population.

Area of Science:

  • Immunology
  • Cardiology
  • Rheumatology

Background:

  • Atherosclerosis is a primary cause of cardiovascular disease (CVD) and mortality.
  • Emerging evidence highlights atherosclerosis as a chronic inflammatory condition with significant immune involvement.
  • Systemic lupus erythematosus (SLE) patients exhibit a markedly elevated risk of CVD, often associated with increased prevalence of vulnerable atherosclerotic plaques.

Purpose of the Study:

  • To explore the complex interplay of risk factors contributing to cardiovascular disease (CVD) in patients with systemic lupus erythematosus (SLE).
  • To investigate the role of both traditional and non-traditional risk factors in predicting CVD outcomes in SLE.
  • To emphasize the importance of managing disease activity and risk factors in SLE patients.

Main Methods:

  • Review of existing literature on atherosclerosis, CVD, and systemic lupus erythematosus.
  • Analysis of traditional risk factors (hypertension, dyslipidemia, smoking, diabetes) in the context of SLE.
  • Examination of non-traditional risk factors, including anti-phospholipid antibodies, systemic inflammation, and specific antibody levels (e.g., anti-phosphorylcholine).

Main Results:

  • Systemic lupus erythematosus (SLE) is associated with a high prevalence of atherosclerosis and vulnerable plaques, increasing cardiovascular disease (CVD) risk.
  • Both traditional risk factors (hypertension, dyslipidemia, smoking, diabetes) and non-traditional factors (anti-phospholipid antibodies, systemic inflammation, low anti-PC antibodies) contribute to CVD risk in SLE.
  • The precise contribution of each traditional risk factor in SLE requires further clarification.

Conclusions:

  • Cardiovascular disease (CVD) prediction in systemic lupus erythematosus (SLE) necessitates consideration of a multifaceted risk profile.
  • Management strategies should address disease activity, specific SLE manifestations, and established cardiovascular risk factors.
  • Further research is needed to elucidate the exact role of traditional risk factors in SLE-related CVD.

Keywords:
antibodiesatherosclerosiscardiovascular diseaseinflammationrisk factorssystemic lupus erythematosus

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.7K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
524
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
471
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
473
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
371
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
724